GABELLI FUNDS LLC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 242 filers reported holding CONMED CORP in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$2,924,650
-27.0%
29,000
-1.7%
0.02%
-20.0%
Q2 2023$4,008,755
+30.8%
29,5000.0%0.03%
+30.4%
Q1 2023$3,063,870
+15.6%
29,500
-1.3%
0.02%
+9.5%
Q4 2022$2,650,336
+8.8%
29,900
-1.6%
0.02%
+5.0%
Q3 2022$2,437,000
-16.3%
30,4000.0%0.02%
-9.1%
Q2 2022$2,911,000
-35.5%
30,4000.0%0.02%
-26.7%
Q1 2022$4,516,000
+3.1%
30,400
-1.6%
0.03%
+7.1%
Q4 2021$4,380,000
+8.3%
30,9000.0%0.03%
+3.7%
Q3 2021$4,043,000
-6.3%
30,900
-1.6%
0.03%0.0%
Q2 2021$4,315,000
+5.2%
31,4000.0%0.03%0.0%
Q1 2021$4,101,000
+11.3%
31,400
-4.6%
0.03%
+3.8%
Q4 2020$3,685,000
+32.3%
32,900
-7.1%
0.03%
+18.2%
Q3 2020$2,785,000
+8.7%
35,400
-0.6%
0.02%
+4.8%
Q2 2020$2,563,000
+25.7%
35,6000.0%0.02%
+16.7%
Q1 2020$2,039,000
-52.9%
35,600
-8.0%
0.02%
-35.7%
Q4 2019$4,328,000
-9.1%
38,700
-21.8%
0.03%
-9.7%
Q3 2019$4,759,000
+11.2%
49,500
-1.0%
0.03%
+14.8%
Q2 2019$4,279,000
-14.3%
50,000
-16.7%
0.03%
-12.9%
Q1 2019$4,991,000
+8.0%
60,000
-16.7%
0.03%
-3.1%
Q4 2018$4,622,000
-20.6%
72,000
-2.0%
0.03%
-3.0%
Q3 2018$5,823,000
+4.7%
73,500
-3.3%
0.03%0.0%
Q2 2018$5,563,000
+9.1%
76,000
-5.6%
0.03%
+10.0%
Q1 2018$5,098,000
+20.5%
80,500
-3.0%
0.03%
+25.0%
Q4 2017$4,231,000
-2.8%
83,0000.0%0.02%
-4.0%
Q3 2017$4,355,000
+3.0%
83,0000.0%0.02%0.0%
Q2 2017$4,228,000
+12.0%
83,000
-2.4%
0.02%
+13.6%
Q1 2017$3,775,000
+0.6%
85,0000.0%0.02%0.0%
Q4 2016$3,754,000
+10.2%
85,0000.0%0.02%
+10.0%
Q3 2016$3,405,000
-16.1%
85,0000.0%0.02%
-16.7%
Q2 2016$4,057,000
+13.8%
85,0000.0%0.02%
+14.3%
Q1 2016$3,565,000
-4.8%
85,0000.0%0.02%
-8.7%
Q4 2015$3,744,000
-7.7%
85,0000.0%0.02%
-4.2%
Q3 2015$4,058,000
-20.9%
85,000
-3.4%
0.02%
-11.1%
Q2 2015$5,128,000
+15.4%
88,0000.0%0.03%
+17.4%
Q1 2015$4,443,000
+11.0%
88,000
-1.1%
0.02%
+21.1%
Q4 2014$4,001,000
+20.7%
89,000
-1.1%
0.02%
+11.8%
Q3 2014$3,316,000
-16.6%
90,0000.0%0.02%
-15.0%
Q2 2014$3,974,000
+0.5%
90,000
-1.1%
0.02%
-4.8%
Q1 2014$3,954,000
+2.2%
91,0000.0%0.02%0.0%
Q4 2013$3,868,000
+18.7%
91,000
-5.2%
0.02%
+10.5%
Q3 2013$3,260,000
+8.7%
96,0000.0%0.02%
+5.6%
Q2 2013$2,999,00096,0000.02%
Other shareholders
CONMED CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Iron Triangle Partners LP 217,204$29,850,0003.08%
Ranger Investment Management 260,524$35,804,0001.87%
EARNEST PARTNERS LLC 1,628,848$223,853,0001.32%
Penn Capital Management Company, LLC 87,232$11,988,0001.16%
DeepCurrents Investment Group LLC 257,334$35,365,0001.06%
Champlain Investment Partners, LLC 1,475,989$202,845,0000.96%
Hood River Capital Management LLC 224,050$30,791,0000.92%
OAK RIDGE INVESTMENTS LLC 74,178$10,194,0000.89%
MOODY ALDRICH PARTNERS LLC 45,667$6,276,0000.88%
WAFRA INC. 138,542$19,040,0000.72%
View complete list of CONMED CORP shareholders